He reliability and validity of the korean version of the structured interview for prodromal syndrome

Psychiatry Investigation

Volumn 7, Issue 4, 2010, Pages 257-263

  Jung, Myung Hun ^a   Jang, Joon Hwan ^a   Kang, Do Hyung ^a   Choi, Jung Seok ^a   Shin, Na Young ^b   Kim, Hee Sun ^b   An, Suk Kyoon ^c   Shin, Min Sup ^a   Kwon, Jun Soo ^a,b  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

He korean version of the structured interview for prodromal syndrome; Reliability; Schizophrenia; Validity

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; COGNITIVE DEFECT; CONCURRENT VALIDITY; CORRELATION COEFFICIENT; FACTORIAL ANALYSIS; FEMALE; HUMAN; INTERNAL CONSISTENCY; INTERRATER RELIABILITY; KOREA; MALE; POSITIVE AND NEGATIVE SYNDROME SCALE; PRODROMAL SYNDROME; PSYCHOSIS; STRUCTURED INTERVIEW; SYMPTOMATOLOGY; SYNDROME;

EID: 79551644126     PISSN: 17383684     EISSN: None     Source Type: Journal    
DOI: 10.4306/pi.2010.7.4.257     Document Type: Article

References (35)

1. Perala J, Suvisaari J, Saarni SI, Kuoppasalmi K, Isometsa E, Pirkola S, et al. Lifetime prevalence of psychotic and bipolar i disorders in a general population. Arch Gen Psychiatry 2007;64:19-28.
2. Regier DA, Narrow WE, Rae DS, Manderscheid RW, Locke BZ, Goodwin FK. hedefacto US mental and addictive disorders service system. Epidemiologic catchment area prospective 1year prevalence rates of disorders and services. Arch Gen Psychiatry 1993;50:85-94.
3. Harrigan SM, McGorry PD, Krstev H. Does treatment delay in irstepisode psychosis really matter? Psychol Med 2003;33:97-110.
4. Norman RM, Malla AK. Duration of untreated psychosis: a critical examination of the concept and its importance. Psychol Med 2001;31: 381-400.
5. McGorry PD, Singh BS. Schizophrenia: title typecontributorrisk and possibility of prevention, in Handbook of Studies on Preventive Psychiatry/title. Amsterdam: Elsevier Science; 1995.
6. Yung AR, Yuen HP, McGorry PD, Phillips LJ, Kelly D, Dell'Olio M, et al. Mapping the onset of psychosis: the Comprehensive Assessment of AtRisk Mental States. Aust N Z J Psychiatry 2005;39:964-971.
7. Miller TJ, McGlashan TH, Rosen JL, Cadenhead K, Cannon T, Ventura J, et al. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr Bull 2003; 29:703-715.
8. Miller TJ, McGlashan TH, Woods SW, Stein K, Driesen N, Corcoran CM, et al. Symptom assessment in schizophrenic prodromal states. Psychiatr Q 1999;70:273-287.
9. McGlashan TH, Miller TJ, Woods SW, Hofman RE, Davidson L. A scale for the assessment of prodromal symptoms and states. Dordrecht: Kluwer Academic Publishers; 2001.
10. Woods SW, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen R, et al. Validity of the prodromal risk syndrome for irst psychosis: indings from the North American Prodrome Longitudinal Study. Schizophr Bull 2009;35:894-908.
11. LemosGiraldez S, VallinaFernandez O, FernandezIglesias P, VallejoSeco G, FonsecaPedrero E, PainoPineiro M, et al. Symptomatic and functional outcome in youth at ultrahigh risk for psychosis: a longitudinal study. Schizophr Res 2009;115:121-129.
12. Lemos S, Vallina O, Fernandez P, Ortega JA, Garcia P, Gutierrez A, et al. [Predictive validity of the Scale of Prodromal Symptoms (SOPS)]. Actas Esp Psiquiatr 2006;34:216-223.
13. Yoo SY, Lee KJ, Kang DH, Lee SJ, Ha TH, Wee W, et al. Characteristics of subjects at clinical high risk for schizophrenia: natural follow up study in 'Seoul Youth Clinic'pilot study. J Korean Neuropsychiatr Assoc 2007;46:19-28.
14. Yi JS, Ahn YM, Shin HK, An SK, Joo YH, Kim SH, et al. Reliability and validity of the Korean version of the Positive and Negative Syndrome Scale. J Korean Neuropsychiatr Assoc 2001;40:1090-1105.
15. First MB, Spitzer RL, Gibbon M, Wiliams JB. Structured Clinical Interview for DSMIV Axis I Disorders. New York: Biometrics Research; 1997.
16. American Psychiatric Association. DSMIV: Diagnostic and Statistical Manual of Mental Disorders. 4th edition. Washington, DC: American Psychiatric Association, 1994.
17. Andreasen NC, Endicott J, Spitzer RL, Winokur G. he family history method using diagnostic criteria. Reliability and validity. Arch Gen Psychiatry 1977;34:1229-1235.
18. Hall RC. Global assessment of functioning. A modiied scale. Psychosomatics 1995;36:267-275.
19. McGraw KO, Wong SP. Forming Inferences About Some Intraclass Correlation Coeicients. Psychol Methods 1996;1:30-46.
20. Fleiss JL. Analysis of data from multiclinic trials. Control Clin Trials 1986; 7:267-275.
21. Nunnally JC, Bernstein IH. Psychometric theory. New York: McGrawHill; 1994.
22. Cattell RB. he scree test for the number of factors. Multivariate Behav Res 1996;1:245-276.
23. Gorsuch RL. Factor Analysis. Hillsdale: Lawrence Erlbaum Associates; 1983.
24. Muthen LK, Muthen BO. How to use a Monte Carlo study to decide on sample size and determine power. Struct Equ Modeling 2002;9:599-620.
25. hurstone LL. Multiplefactor analysis. Chicago, IL: Chicago Press; 1947.
26. Lindenmayer JP, Grochowski S, Hyman RB. Five factor model of schizophrenia: replication across samples. Schizophr Res 1995;14:229-234.
27. Yung AR, Phillips LJ, Yuen HP, Francey SM, McFarlane CA, Hallgren M, et al. Psychosis prediction: 12month follow up of a highrisk ("prodromal") group. Schizophr Res 2003;60:21-32.
28. Yung AR, Yuen HP, Berger G, Francey S, Hung TC, Nelson B, et al. Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk? Schizophr Bull 2007;33:673-681.
29. Cannon TD, Cadenhead K, Cornblatt B, Woods SW, Addington J, Walker E, et al. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry 2008;65:28-37.
30. Peralta V, Cuesta MJ. Psychometric properties of the positive and negative syndrome scale (PANSS) in schizophrenia. Psychiatry Res 1994;53: 31-40.
31. von Knorring L, Lindström E. he Swedish version of the Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Construct validity and interrater reliability. Acta Psychiatr Scand 1992;86:463-468.
32. Hawkins KA, McGlashan TH, Quinlan D, Miller TJ, Perkins DO, Zipursky RB, et al. Factorial structure of the Scale of Prodromal Symptoms. Schizophr Res 2004;68:339347.
33. Kawasaki Y, Maeda Y, Sakai N, Higashima M, Urata K, Yamaguchi N, et al. Evaluation and interpretation of symptom structures in patients with schizophrenia. Acta Psychiatr Scand 1994;89:399-404.
34. Lindenmayer JP, BernsteinHyman R, Grochowski S, Bark N. Psychopathology of Schizophrenia: initial validation of a 5factor model. Psychopathology 1995;28:22-31.
35. Lancon C, Auquier P, Nayt G, Reine G. Stability of the ivefactor structure of the Positive and Negative Syndrome Scale (PANSS). Schizophr Res 2000;42:231-239.